Skip to content
Top Globe News – Lifestyle
Author:
HANCHORBIO INC.
HanchorBio to List on Taiwan Innovation Board at NT$120 per Share as HCB101 Clinical Data Support Global Partnering Discussions
May 28, 2026
HanchorBio Prices IPO at NT$120 Ahead of Innovation Board Listing on May 29
May 26, 2026
HanchorBio Selects Bloomberg to Strengthen its Strategic Intelligence Across Drug Development and Global Biopharma
April 29, 2026
HanchorBio Advances Toward TWSE Innovation Board Listing to Accelerate Global Clinical Development, Platform Expansion, and International Partnering
March 25, 2026